Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014

Autor: Lukas J.A. Stalpers, Charles G.H.J. Niël, Hanneke Vos-Westerman, Johanna G. H. van Nes, Joost J. Nuyttens, Peter Koper, Tom Rozema, Jaap D. Zindler, Kim C. de Vries, Paul M. Jeene, Joost J.C. Verhoeff, Ilona Schmeets, Johannes J.M. Kwakman, Pètra M. Braam, Yvette M. van der Linden, Stefan Hutschemaekers, G. Wester

Publikováno v: Acta Oncologica, 57, 637-643
Acta Oncologica, 57, 5, pp. 637-643
Acta Oncologica, 57(5), 637-643. Informa Healthcare
Acta Oncologica, 57, 637. Informa Healthcare
Acta Oncologica, 57(5), 637-643
Jeene, P M, de Vries, K C, van Nes, J G H, Kwakman, J J M, Wester, G, Rozema, T, Braam, P M, Zindler, J D, Koper, P, Nuyttens, J J, Vos-Westerman, H A, Schmeets, I, Niël, C G H J, Hutschemaekers, S, van der Linden, Y M, Verhoeff, J J C & Stalpers, L J A 2018, ' Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014 ', Acta Oncologica, vol. 57, no. 5, pp. 637-643 . https://doi.org/10.1080/0284186X.2017.1418534
Acta oncologica (Stockholm, Sweden), 57(5), 637-643. Informa Healthcare
Acta Oncologica, 57(5), 637-643. Routledge/Taylor & Francis Group

Background: Whole brain radiotherapy (WBRT) is considered standard of care for patients with multiple brain metastases or unfit for radical treatment modalities. Recent studies raised discussion about the expected survival after WBRT. Therefore, we a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beae62b1212fd0f12b93f463c2e215a3
https://doi.org/10.1080/0284186x.2017.1418534

Target volume delineation variation in radiotherapy for early stage rectal cancer in the Netherlands

Autor: Dankert Woutersen, Karijn M.S. Verschueren, Debby Geijsen, Martijn Intven, Marcel van Herk, Annerie Slot, Jannet C. Beukema, Jasper Nijkamp, Yvette M. van der Linden, Hanneke Vos-Westerman, Heleen M. Ceha, Tom Rozema, Patty H. Spruit, Karen J. Neelis, Danielle F. M. de Haas-Kock, Corrie A.M. Marijnen

Publikováno v: Nijkamp, J, de Haas-Kock, D F, Beukema, J C, Neelis, K J, Woutersen, D, Ceha, H, Rozema, T, Slot, A, Vos-Westerman, H, Intven, M, Spruit, P H, van der Linden, Y, Geijsen, D, Verschueren, K, van Herk, M B & Marijnen, C A 2012, ' Target volume delineation variation in radiotherapy for early stage rectal cancer in the Netherlands ', Radiotherapy & Oncology, vol. 102, no. 1, pp. 14-21 .
Radiotherapy and Oncology, 102(1), 14-21. ELSEVIER IRELAND LTD
Radiotherapy and oncology, 102(1), 14-21. Elsevier Ireland Ltd
Aarhus University
Nijkamp, J, de Haas-Kock, D F M, Beukema, J C, Neelis, K J, Woutersen, D, Ceha, H, Rozema, T, Slot, A, Vos-Westerman, H, Intven, M, Spruit, P H, van der Linden, Y, Geijsen, D, Verschueren, K, van Herk, M B & Marijnen, C A M 2012, ' Target volume delineation variation in radiotherapy for early stage rectal cancer in the Netherlands ', Radiotherapy and Oncology, vol. 102, no. 1, pp. 14-21 . https://doi.org/10.1016/j.radonc.2011.08.011
Radiotherapy and Oncology, 102(1), 14-21. Elsevier Ireland Ltd
Radiotherapy and Oncology, 102(1), 14-21

Purpose: The aim of this study was to measure and improve the quality of target volume delineation by means of national consensus on target volume definition in early-stage rectal cancer.Methods and materials: The CTV's for eight patients were deline

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a874c3a8ace1ff6e2d6bcf82afcdca0c
https://pure.au.dk/portal/da/publications/target-volume-delineation-variation-in-radiotherapy-for-early-stage-rectal-cancer-in-the-netherlands(661b45b7-dcda-471c-abe2-5b1bb02c6c38).html